A micro-sized vaccine based on recombinant Lactiplantibacillus plantarum fights against SARS-CoV-2 infection via intranasal immunization
COVID-19
Mucosal vaccines
Lactiplantibacillus plantarum
Microparticle
Intranasal administration
Viral challenge
Mice
Lung targeting delivery system
© 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
留言 (0)